Disclosed is a compound of Formula (1.0) or a pharmaceutically acceptable salt or solvate thereof, wherein AR1 represents (a), AR2 represents (b) or a five-membered heterocyclic aromatic group selected from the group consisting of Formulas (I to XII), wherein the substitutable carbon atoms of the five-membered heterocyclic group can optionally be substituted with a group R1. Also disclosed are pharmaceutical compositions containing compounds of Formula (1.0). Further disclosed is a method for treating asthma, allergy and inflammation by administering an anti-asthmatic, anti-allergic or anti-inflammatory, respectively, effective amount of a compound of Formula (1.0).